CCL21 activation of the MALAT1/SRSF1/mTOR axis underpins the development of gastric carcinoma

BACKGROUND: As a significant cause of malignancy mortality, gastric carcinoma (GC) has been well documented to be an often-fatal diagnosis. Despite the limitations of effective therapy, immunotherapy has emerged as a promising therapeutic approach capable of killing cancer cells via the immune syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Qianmei, Tan, Xiaohong, Tang, Huaming, Liu, Jijiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127212/
https://www.ncbi.nlm.nih.gov/pubmed/34001131
http://dx.doi.org/10.1186/s12967-021-02806-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127212/
https://www.ncbi.nlm.nih.gov/pubmed/34001131
http://dx.doi.org/10.1186/s12967-021-02806-5

Ejemplares similares